Colon Hydrotherapy, Colonic Naysa Nuri Colon Hydrotherapy, Colonic Naysa Nuri

Key Market Trends in Colon Hydrotherapy

Check out this scientific study discussing key growth factors, trends, and health benefits of colon hydrotherapy.

Source: https://www.mordorintelligence.com/industry-reports/colon-hydrotherapy-market

The colon hydrotherapy market is expected to register a CAGR of 4% over the forecast period, (2022-2027).

Covid-19 has hampered the colon hydrotherapy market in the initial phase. The rise in restrictions and lockdowns increased, followed by the cancellation of medical procedures. This resulted in delays in colonic hydrotherapy procedures. And the market was impacted negatively by the pandemic. However, the chances of rising gastrointestinal issues increased related to Covid-19 infection. An article published in April 2022, “Squamous Metaplasia of the Colon Following Severe COVID-19,” reported that SARS-CoV-2 enters the intestinal mucosa and causes gastrointestinal symptoms such as diarrhea or abdominal pain. Also, during the study, extensive mucosal sloughing in the small intestine and colon has been reported in Covid-19-affected patients. Hence, this created demand for colon hydrotherapy procedures to cleanse the colon. Therefore, the Covid-19 pandemic has significantly impacted the colon hydrotherapy market.

Factors such as the increasing prevalence of colon cancer and technological advancements in diagnostic tools for colon hydrotherapy are driving the growth of the studied market. Additionally, rising investment in healthcare globally is a major factor that creates new opportunities for the colon hydrotherapy market. As per the report Published in 2022 by Information Resources Incorporated (IRI), Germany is one of the major countries with advanced healthcare systems and technologies, and the country invests more in healthcare. In 2022, healthcare spending in Germany exceeded USD 143.1 billion. These increasing healthcare spending in countries worldwide is creating more opportunities for medical procedures such as colon hydrotherapy or colonic irrigation. Thus, anticipated to drive the growth of the studied market over the forecast period.

Moreover, the developments and rise in the adoption of colon hydrotherapy in hospital and clinical settings are driving the overall market growth. For instance, in July 2022, Medtronic expanded health equity assistance program for colon cancer screening with support from Amazon Web Services; completed first installation of donated GI Genius intelligent endoscopy modules. Thus, the increasing availability of colonic hydrotherapy services among end-users is booming the demand for colonic hydrotherapy, which ultimately drives the overall studied market.

In addition, the increasing colon cancer globally is one of the prime factors which is bolstering the market growth. As per World health organization (WHO) data updated in February 2022, colon cancer is one of the most common cancers in the population and an estimated 1.93 million new cases of colon and rectum cancers were there globally in the year 2020. The procedure is known for its benefits, such as removing toxins, boosting energy, improving the immune system, helping with weight loss, improving digestion, and preventing colon cancer. Hence, the increasing colon cancer worldwide is predicted to generate demand for colon hydrotherapy procedures. Hence, the market studied is anticipated to see growth over the forecast period.

Therefore, owing to the above-mentioned factors, the overall market studied is anticipated to grow over the future. However, a lack of awareness about technological advancements in diagnostic tools for colon hydrotherapy might hinder the market growth.

Scope of the Report

As per the scope of the report, colon hydrotherapy is also known as colonic cleansing or colonic irrigation. This involves using water to flush waste, toxins, and infections out of the large intestine. The colon hydrotherapy market is segmented by Unit Type (Mobile Hydrotherapy, Fixed Hydrotherapy), System (Open and Closed), End-User (Hospitals, Therapy Centers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above-mentioned segments.

North America is Expected to Dominate the Market Over the Forecast Period

North America is expected to dominate the market. Factors such as the easy availability of technologically advanced products, and the high prevalence of minimally invasive surgeries coupled with increasing chronic diseases in the countries in the region, are among other major factors responsible for the growth of the market in the region.

In North America, the United States is expected to hold a major market share during the forecast period due to the high prevalence of colon and rectum cancer. The Cancer Facts & Figures 2022, American Cancer Society shows that an estimated 106,180 colon cancer as new cancer cases will be diagnosed in the United States, with 54,040 males and 52,140 females prevalence in 2022. This prevalence of colon cancer in the United States is creating a demand for colon cleansing, which is usually preferred prior to colonoscopy. Therefore, the rising prevalence of colon cancer is anticipated to drive the overall studied market growth in the United States.

Additionally, the increasing development and initiatives in the countries across the United States are majorly bolstering the studied market growth in the region. For instance, in October 2021, Colon Therapy Certification and Certificate Program was conducted in the top 10 Schools in the United States for Students, and they are required to complete at least 100 hours of training in these programs. Thus, the awareness among the students is anticipated to boost the colon hydrotherapy demand, propelling the growth of the studied market.

Moreover, the rise in investments in hospital infrastructure in countries of North America is predicted to contribute to the market growth in the region. For instance, in April 2022, the Jalisco government announced to invest more than USD301.5 million in health care infrastructure over the next three years to build new hospitals and health care centers and upgrade existing ones. These government investments are predicted to provide a new opportunity for colon hydrotherapy in hospital and clinic settings, bolstering the overall market growth in the region.

Therefore, owing to the previously mentioned factors, the growth of the studied market is predicted in the North American region.

To understand geography trends, Download Sample Report

Competitive Landscape

The colon hydrotherapy market is competitive and consists of many major players, along with multiple smaller companies. With technological advancements and product innovations, mid-size to smaller companies are increasing their market presence globally. The competitive landscape includes an analysis of several companies which hold most of the market shares and are well known. Some of the major players are Prime Pacific Health Innovations Corporation, TRANSCOM, Cerajivan Healthtech, Herrmann Apparatebau, and Lifotronic Technology Co. Ltd., among others.

Major Players

  1. Prime Pacific Health Innovations Corporation

  2. TRANSCOM

  3. Cerajivan Healthtech

  4. Lifotronic Technology Co. Ltd.

  5. Herrmann Apparatebau GmbH

Recent Development

  • In April 2022, Motus GI Holdings, Inc., a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced the enrollment of the final patient in the European Union (EU) study of the Pure-Vu System, which is evaluating the clinical outcomes in patients with a history of poor bowel preparation using both a low volume preparation with limited diet restrictions and the Pure-Vu System.

  • In February 2022, Motus GI Holdings, Inc. received 510(k) clearance from the Food and Drug Administration (FDA) for the Pure-Vu EVS System. The new Pure-Vu EVS System is intended to improve the speed of set-up, enhance navigation capabilities in tortuous anatomy, build upon the Pure-Vu system's excellent cleansing capabilities, and enable physicians to rapidly overcome the challenges of poorly prepared colons during a colon

Read More